Vinci, a Palo Alto-based startup developing AI-driven physics simulation for hardware engineering, raised $250 million at a $1.5 billion valuation. The round was led by Advent, Temasek, and Xora Innovation, with participation from Eclipse, Khosla Ventures, and Madrona. The company plans to expand its thermal modeling software into full-system simulation.
Spiko, based in London and Paris, secured $90 million in a Series B round led by New Enterprise Associates. The company provides tokenized money-market funds for corporate treasury management and currently reports $2.7 billion in assets under management. The funding brings its total capital raised to $120 million.
Dutch biotech company RougeTx launched with a $58 million Series A round co-led by BioGeneration Ventures, Angelini Ventures, and Kurma Partners. The capital will support the development of its lead drug candidate, RTX-001, aimed at treating hereditary hemorrhagic telangiectasia, as well as its periSCOPE platform.
Amsterdam-based cybersecurity firm Hadrian raised $40 million in a round co-led by Forgepoint Capital International and SmartFin. The company utilizes AI for continuous attack-surface monitoring and penetration testing. Existing investors, including HV Capital and Picus Capital, also participated, bringing the total funding to $65 million.
WhiteLab Genomics, headquartered in Paris, secured $26 million in a Series B round. The company focuses on combining AI-designed genomic assets with experimental validation. This investment is part of a broader trend where capital is increasingly directed toward specialized, AI-native vertical technology companies.
